Every round on record, with the sources behind each and the investors on them.
CereGate sells a computer-brain interface platform that powers therapeutic solutions for restoring and reimagining human senses.
ceregate.comLinkedInMunich, GermanyMedtechFounded 2019
1 source
Developing: it holds up against its sources so far, and firms up as more reporting lands.
The source announces financing structured as a capital increase and convertible, but states no stage, amount, valuation, or headquarters. High-Tech Gründerfonds is named as providing the financing, not as a lead.
| Round | Amount | Announced | Lead | Buzz |
|---|---|---|---|---|
| Convertible capital increase and convertible [ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it. | n/a | 2020-01-23 | not stated | No recent discussion |
1 source [ DEVELOPING ] Developing: it holds up against its sources so far, and firms up as more reporting lands. read against 1 source
The source announces financing structured as a capital increase and convertible, but states no stage, amount, valuation, or headquarters. High-Tech Gründerfonds is named as providing the financing, not as a lead. | ||||
CereGate builds a hardware-agnostic computer-brain interface software platform that works with existing neuromodulation implants to provide therapeutic solutions for people with neurological disorders.
Checked against 8 sources yesterday
| EARLIER ROUNDS FROM COMPANY RESEARCH · DEVELOPING | ||||
| Seed | n/a | 2020-01-23 | not stated | |
Also named as backers in company research: Heal Capital, TruVenturo, 468 Capital, re.Mind Capital, Impact Ventures